"We provide help and inspire hope to those affected by cancer through high quality, advanced oncology and hematology cancer treatments and leading-edge technology."

During the past decade, Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Pfizer" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Celgene Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" are "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Cancer" (1 trials) and "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials). Many other conditions were trialed in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" in a lesser frequency.

Most popular intervention types in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" are "Drug" (16 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (5 trials), "Placebo" (5 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" are 12 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".